Expression of human proteins in a readily usable heterologous system is a powerful mean to study their function and structure and to discover novel targets and therapeutic routes directly associated with the causes of disease. Common yeast is ideal to adapt this technology to the human genome scale. Yet many laboratories have the same fundamental problem - the failure of many membrane proteins (the main target of pharmaceutical products) to be functionally expressed in yeast due to incorrect delivery or maintenance at the plasma membrane. The EFFEXPORT project aims to engineer yeast into a more reliable system for expression of heterologous membrane transporters. The novel yeast strains and associated strategies will be used to develop a new type of screening assay for identifying chemical compounds that act selectively on transporters of interest.
Funding SchemeCSC - Cost-sharing contracts
142 20 Praha 4
60054 Frankfurt Am-main
171 77 Stockholm
69978 Ramat - Aviv